Zymes Bioscience Private Limited, a active private limited company, was established on 09 April 2012 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51102DL2012PTC234105. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 51 professional, Its leadership includes Chandan Chopra (Director), Shivali Choudhary (Director). Past directors included Chandan Chopra, Suchinder Kaur, Mohit Bhatia. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 1 ,2Nd Floor, B-20 Okhla Industrial Area Ph-2, New Delhi, Delhi, 110020.
U51102DL2012PTC234105
234105
09 April 2012
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zymes Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandan Chopra | Director | 01 May 2024 | Current |
| Shivali Choudhary | Director | 25 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Aug 2020 | Past |
| Pramod Abcsdd | Director | 26 May 2022 | Past |
| Pramod Abcsdd | Director | 26 Aug 2017 | Past |
| Pramod Abcsdd | Director | 16 Mar 2018 | Past |
| Pramod Abcsdd | Director | 22 May 2021 | Past |
| Pramod Abcsdd | Director | 02 May 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zymes Bioscience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 126.94% increase. The company also saw a substantial improvement in profitability, with a 27.82% increase in profit. The company's net worth Soared by an impressive increase of 127.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Zymes Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Zymes Bioscience has a workforce of 51 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zymes Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zymes Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Zymes Bioscience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Chandan Chopra was appointed as a Director was appointed as a Director on 01 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Progress on Zymes Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Shivali Choudhary was appointed as a Director was appointed as a Director on 25 May 2022 & has been associated with this company since 3 years 6 months . was documented.
The activity Zymes Bioscience Private Limited was registered on 09 Apr 2012 with Roc Delhi & aged 13 years 7 months as per MCA records. was completed.
The CIN of Zymes Bioscience Private Limited is U51102DL2012PTC234105.
Zymes Bioscience Private Limited is headquartered at Office No. 1 ,2Nd Floor, B-20 Okhla Industrial Area Ph-2, New Delhi, Delhi, 110020.
Zymes Bioscience Private Limited was incorporated on 09 April 2012.
The current directors of Zymes Bioscience Private Limited are
The primary industry of Zymes Bioscience Private Limited is Manufacturing.
Zymes Bioscience Private Limited is unlisted.
The authorized capital of Zymes Bioscience Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Zymes Bioscience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX